World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: Netherlands Trial Register
Last refreshed on: 28 April 2013
Main ID:  NTR2583
Date of registration: 02/11/2010
Primary sponsor: Erasmus Medical Center
Public title: e-Monitoring of Asthma Therapy to Improve Compliance in children.
Scientific title: The use of a Real-Time Medication Monitoring system (RTMM) for the improvement of adherence to inhalation corticosteroids in children with asthma. - e-MATIC
Date of first enrolment: 1/1/2011
Target sample size: 220
Recruitment status: pending
URL:  http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2583
Study type:  intervention
Study design:  Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: 2 or more arms, randomized  
Countries of recruitment
The Netherlands
Contacts
Name: E.C.  Vasbinder
Address:  Erasmus MC Afdeling apotheek Cluster 7 Postbus 2040 3000 CA Rotterdam The Netherlands
Telephone: +31 (0)10 7033202
Email: erwinvasbinder@gmail.com
Affiliation: 
Name: P.M.L.A.  Bemt, van den
Address:  Utrecht University Faculty of Science - Utrecht Institute for Pharmaceutical Sciences - Division of Pharmacoepidemiology & Pharmacotherapy PO Box 80 082 3508 TB Utrecht The Netherlands
Telephone: +31 (0)30 2534042
Email: p.vandenbemt@uu.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Children younger than 12 years old;

2. Diagnosed with asthma for at least 6 months;

3. ICS use for at least 3 months using a pMDI;

4. At least one parent or care giver has a mobile phone.

Exclusion criteria: Refusal to participate in the study.

Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Asthma, Inhaled corticosteroids, Compliance, Real time medication monitoring (RTMM), Text-messaging reminder

Intervention(s)
All children will receive a real time medication monitoring (RTMM) device that is connected to the pressurized metered dose inhaler (pMDI) with inhaled corticosteroids (ICS). Immediately after each inhalation, a signal is sent to the research database. This information is compared to the expected time of inhalation and thus adherence is determined. Only in the intervention group, sms-reminders are sent to parents of children that are at risk of forgetting to take their ICS.
Primary Outcome(s)
Percentage of inhalations taken within a 6 hour timeframe around the expected time of inhalation.
Secondary Outcome(s)
1. Asthma controll;

2. Asthma exacerbations;

3. Disease specific quality of life;

4. Acceptance of e-monitoring bij parents and children.

Moreover, an economic evaluation will be performed adopting a societal perspective, including all relevant healthcare costs and productivity loss of the parents.
Secondary ID(s)
34219
Source(s) of Monetary Support
ZON-MW, The Netherlands Organization for Health Research and Development
Secondary Sponsor(s)
Evalan BV
GlaxoSmithKline (GSK)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history